文献速递临床试验与 GCP基础与转化研究组学、生物样本库与精准医学

地中海饮食对急性冠脉综合征后冠状动脉斑块易损性、微血管功能、炎症与微生物组的影响:MEDIMACS随机对照机制性临床试验的研究方案

The impact of Mediterranean diet on coronary plaque vulnerability, microvascular function, inflammation and microbiome after an acute coronary syndrome: study protocol for the MEDIMACS randomized, controlled, mechanistic clinical trial.
PubMed 文献 · Trials · 2021-11-12

MEDIMACS是一项学术资助的前瞻性随机对照机制性临床试验,纳入100例急性冠脉综合征患者,1:1随机分配至强化地中海饮食干预组或标准治疗组。主要终点为基线至12个月非罪犯血管非显著性斑块纤维帽厚度的变化,采用光学相干断层扫描评估。

要点

  • 强化地中海饮食干预对比标准治疗,评估对冠状动脉斑块易损性的影响。
  • 主要终点为12个月非罪犯血管非显著性斑块纤维帽厚度变化。
  • 次要终点包括冠状动脉血管生理学指标、胃肠道微生物群、免疫状态及蛋白代谢谱变化。

核心结论

  • 该试验结果将探讨饮食习惯对动脉粥样硬化风险的关键影响,并提供免疫、微生物组、蛋白质组和代谢组相关机制复杂相互作用的初步数据,这些非药物因素可能影响急性冠脉综合征后冠状动脉粥样硬化的进展。

研究设计与样本

  • MEDIMACS项目是一项学术资助的前瞻性随机对照机制性临床试验,纳入100例急性冠脉综合征患者,按1:1随机分配至监测下的高强度地中海饮食干预组或标准治疗组。
  • 饮食依从性通过食物频率问卷和依从性生物标志物在两组中评估。

主要发现

  • 主要终点为基线至12个月非罪犯血管中非显著性动脉粥样硬化斑块纤维帽厚度的变化,通过重复光学相干断层扫描冠状动脉内成像评估。
  • 次要终点包括冠状动脉血管生理学指标以及胃肠道微生物群、免疫状态、蛋白质和代谢物谱的变化。

关键数值与推荐

  • 主要终点:基线至12个月非罪犯血管非显著性斑块纤维帽厚度变化,采用光学相干断层扫描评估。
  • 次要终点:冠状动脉血管生理学指标、胃肠道微生物群变化、免疫状态、蛋白质和代谢物谱变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Primary prevention trials have demonstrated that the traditional Mediterranean diet is associated with a reduction in cardiovascular mortality and morbidity. However, this benefit has not been proven for secondary prevention after an acute coronary syndrome (ACS). We hypothesized that a high-intensity Mediterranean diet intervention after an ACS decreases the vulnerability of atherosclerotic plaques by complex interactions between anti-inflammatory effects, microbiota changes and modulation of gene expression. METHODS: The MEDIMACS project is an academically funded, prospective, randomized, controlled and mechanistic clinical trial designed to address the effects of an active randomized intervention with the Mediterranean diet on atherosclerotic plaque vulnerability, coronary endothelial dysfunction and other mechanistic endpoints. One hundred patients with ACS are randomized 1:1 to a monitored high-intensity Mediterranean diet intervention or to a standard-of-care arm. Adherence to diet is assessed in both arms using food frequency questionnaires and biomarkers of compliance. The primary endpoint is the change (from baseline to 12 months) in the thickness of the fibrous cap of a non-significant atherosclerotic plaque in a non-culprit vessel, as assessed by repeated optical coherence tomography intracoronary imaging. Indices of coronary vascular physiology and changes in gastrointestinal microbiota, immunological status and protein and metabolite profiles will be evaluated as secondary endpoints. DISCUSSION: The results of this trial will address the key effects of dietary habits on atherosclerotic risk and will provide initial data on the complex interplay of immunological, microbiome-, proteome- and metabolome-related mechanisms by which non-pharmacological factors may impact the progression of coronary atherosclerosis after an ACS. TRIAL REGISTRATION: ClinicalTrials.gov NCT03842319 . Registered on 13 May 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fernández AI, Bermejo J, Yotti R, et al. The impact of Mediterranean diet on coronary plaque vulnerability, microvascular function, inflammation and microbiome after an acute coronary syndrome: study protocol for the MEDIMACS randomized, controlled, mechanistic clinical trial. Trials. 2021. PMID: 34772433. doi:10.1186/s13063-021-05746-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。